PL1756111T3 - Alkilo-podstawione indolochinoksaliny - Google Patents

Alkilo-podstawione indolochinoksaliny

Info

Publication number
PL1756111T3
PL1756111T3 PL05742482T PL05742482T PL1756111T3 PL 1756111 T3 PL1756111 T3 PL 1756111T3 PL 05742482 T PL05742482 T PL 05742482T PL 05742482 T PL05742482 T PL 05742482T PL 1756111 T3 PL1756111 T3 PL 1756111T3
Authority
PL
Poland
Prior art keywords
lower alkyl
alkyl
alkyl substituted
similar
indoloquinoxalines
Prior art date
Application number
PL05742482T
Other languages
English (en)
Inventor
Jan Bergman
Robert Engqvist
Bengt Gerdin
Ingemar KIHLSTRÖM
Ulf Björklund
Original Assignee
Oxypharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxypharma Ab filed Critical Oxypharma Ab
Publication of PL1756111T3 publication Critical patent/PL1756111T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
PL05742482T 2004-06-17 2005-05-18 Alkilo-podstawione indolochinoksaliny PL1756111T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0401555A SE527639C2 (sv) 2004-06-17 2004-06-17 Alkylsubstituerade indolokinoxaliner
EP05742482A EP1756111B1 (en) 2004-06-17 2005-05-18 Alkyl substituted indoloquinoxalines
PCT/SE2005/000718 WO2005123741A1 (en) 2004-06-17 2005-05-18 Alkyl substituted indoloquinoxalines

Publications (1)

Publication Number Publication Date
PL1756111T3 true PL1756111T3 (pl) 2010-08-31

Family

ID=32710074

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05742482T PL1756111T3 (pl) 2004-06-17 2005-05-18 Alkilo-podstawione indolochinoksaliny

Country Status (23)

Country Link
US (2) US7589093B2 (pl)
EP (1) EP1756111B1 (pl)
JP (1) JP5038891B2 (pl)
CN (1) CN1976934B (pl)
AT (1) ATE462707T1 (pl)
AU (1) AU2005254919B2 (pl)
BR (1) BRPI0512086A (pl)
CA (1) CA2568592C (pl)
CY (1) CY1110145T1 (pl)
DE (1) DE602005020283D1 (pl)
DK (1) DK1756111T3 (pl)
ES (1) ES2342946T3 (pl)
IL (1) IL179171A (pl)
MX (1) MXPA06014170A (pl)
NO (1) NO20070289L (pl)
NZ (1) NZ551780A (pl)
PL (1) PL1756111T3 (pl)
PT (1) PT1756111E (pl)
RU (1) RU2369609C2 (pl)
SE (1) SE527639C2 (pl)
SI (1) SI1756111T1 (pl)
WO (1) WO2005123741A1 (pl)
ZA (1) ZA200700358B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE529777C2 (sv) * 2006-01-23 2007-11-20 Vironova Ab Nya föreningar och användning därav
JP5454750B2 (ja) 2008-03-05 2014-03-26 東洋製罐株式会社 缶詰の内圧検査方法及びその装置
DE602008001795D1 (de) 2008-04-30 2010-08-26 Univ Duisburg Essen IndolÄ2,3-bÜ-, IndenÄ1,2-bÜ- und IndenÄ2,1-bÜpyridoÄ2,3-fÜ Quinoxalin-3-Carboxylsäuren und Ester, Verfahren zu ihrer Herstellung und ihre Verwendung als Antivirus- und Antitumormittel
EP2489354A1 (en) 2011-02-18 2012-08-22 Vironova AB Pharmaceutical formulation of B220 for topical treatment of herpes
CN103211960B (zh) * 2012-01-18 2017-10-13 金士力佳友(天津)有限公司 具有降血糖作用的中药组合物、其应用及制备方法
WO2014140321A1 (en) * 2013-03-15 2014-09-18 Vironova Ab Antiviral indolo[2,3-b]quinoxaline
KR20230022881A (ko) 2020-06-10 2023-02-16 사익손 아베 류마티스 관절염의 치료에서의 라벡시모드
EP4164649A1 (en) 2020-06-10 2023-04-19 Cyxone AB New use of rabeximod
JP2023543089A (ja) 2020-09-21 2023-10-12 ヴィロノヴァ・メディカル・アクチェボラーグ 炎症性障害および自己免疫障害の治療のためのラベキシモド（ｒａｂｅｘｉｍｏｄ）のチオノエステル誘導体
US11643415B1 (en) 2021-12-09 2023-05-09 Cyxone Ab Rabeximod compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504862C2 (sv) 1994-12-27 1997-05-20 Leif J I Lundblad Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler
US6333327B2 (en) 2000-02-18 2001-12-25 Leif J. I. Lundblad Method for the treatment of Multiple Sclerosis
SE516067C2 (sv) 2000-02-18 2001-11-12 Lundblad Leif J I Användning av en förening för framställning av ett läkemedel

Also Published As

Publication number Publication date
US8084453B2 (en) 2011-12-27
SE0401555L (sv) 2005-12-18
CY1110145T1 (el) 2015-01-14
ZA200700358B (en) 2008-07-30
PT1756111E (pt) 2010-06-01
WO2005123741A1 (en) 2005-12-29
SE0401555D0 (sv) 2004-06-17
CA2568592C (en) 2012-10-30
NZ551780A (en) 2010-05-28
DE602005020283D1 (de) 2010-05-12
JP5038891B2 (ja) 2012-10-03
EP1756111A1 (en) 2007-02-28
US20100009999A1 (en) 2010-01-14
SI1756111T1 (sl) 2010-08-31
AU2005254919B2 (en) 2011-07-21
BRPI0512086A (pt) 2008-02-06
EP1756111B1 (en) 2010-03-31
US7589093B2 (en) 2009-09-15
CA2568592A1 (en) 2005-12-29
IL179171A0 (en) 2007-03-08
US20050288296A1 (en) 2005-12-29
NO20070289L (no) 2007-01-16
SE527639C2 (sv) 2006-05-02
RU2369609C2 (ru) 2009-10-10
ES2342946T3 (es) 2010-07-19
ATE462707T1 (de) 2010-04-15
CN1976934A (zh) 2007-06-06
AU2005254919A1 (en) 2005-12-29
US20110086859A9 (en) 2011-04-14
CN1976934B (zh) 2013-05-29
JP2008502676A (ja) 2008-01-31
RU2007101497A (ru) 2008-07-27
IL179171A (en) 2012-12-31
DK1756111T3 (da) 2010-07-12
MXPA06014170A (es) 2007-05-09

Similar Documents

Publication Publication Date Title
IL179171A0 (en) Alkyl substituted indoloquinoxalines
RS20090249A (en) Spiroketone acetyl-coa carboxylase inhibotors
HK1068334A1 (en) Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
ATE471323T1 (de) Purinderivate als antagonisten an purinergen rezeptoren
ATE453639T1 (de) Phenylsubstituierte pyrimidinverbindungen zur verwendung als kinasehemmer
TW200745032A (en) Novel heterobicyclic derivatives
RS92004A (en) Pyrrolo-triazine aniline compounds useful as kinase inhibitors
MXPA06012595A (es) Analogos de amino-tetrazoles y metodos de uso.
WO2003106428A8 (fr) Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine
MXPA05010652A (es) Pirazoles sustituidos.
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
AP2002002578A0 (en) Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses.
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
TW200503712A (en) (2-carboxamido)(3-amino)thiophene compounds
TW200635594A (en) Phenyl-piperazin methanone derivatives
TW200714593A (en) Agent for treatment of solid tumor
MY136824A (en) Substituted benzoxazinones and uses thereof
TW200720265A (en) Agent for treatment of hematopoietic tumor
MXPA05010651A (es) Compuestos de pirazol.
MXPA05010650A (es) Pirazoles sustituidos.
RS20050445A (en) Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
TW200602046A (en) Pharmaceutical compounds